Vaer Report Details
Age: NA
Gender: Female
State: Outside US
- Patient Died?
- No
- Vaccine information
-
Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Type: Coronavirus 2019 vaccine
Manufacturer: PFIZER
Lot: unknown
- Date report was received
- 2022-03-04
- Date form completed
- Date Vaccinated
- Date of Onset
- 0
- Number of days (onset date – vaccination date)
- 0
- Adverse Event Description
-
my husband and i got sick and we were home together for weeks without separation; my husband and i got sick and we were home together for weeks without separation; i had mild symptoms, postcovid symptoms are fatigue, weakness, internal stress remained; i had mild symptoms, postcovid symptoms are fatigue, weakness, internal stress remained; i had mild symptoms, postcovid symptoms are fatigue, weakness, internal stress remained; i had mild symptoms, postcovid symptoms are fatigue, weakness, internal stress remained; i still breastfeed in the evenings, my little son will be 5 this year; i still breastfeed in the evenings, my little son will be 5 this year; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from medical information team. the reporter is the patient. a 43 year-old female patient received bnt162b2 (comirnaty) (batch/lot number: unknown) as dose 3 (booster), single, (batch/lot number: unknown) as dose 2, single and (batch/lot number: unknown) as dose 1, single for covid-19 immunisation. relevant medical history included: "breast feeding" (ongoing). the patient's concomitant medications were not reported. the following information was reported: drug ineffective (medically significant), suspected covid-19 (medically significant), outcome "unknown" and all described as "my husband and i got sick and we were home together for weeks without separation"; post-acute covid-19 syndrome (non-serious), fatigue (non-serious), asthenia (non-serious), stress (non-serious), outcome "unknown" and all described as "i had mild symptoms, postcovid symptoms are fatigue, weakness, internal stress remained"; off label use (non-serious), product use issue (non-serious), outcome "unknown" and all described as "i still breastfeed in the evenings, my little son will be 5 this year". the clinical course was reported as follows: " i still breastfeed in the evenings; my little son will be 5 this year. i think we have done our best to prevent this thanks to this. my little boy is fine, even if he got it, he went through it asymptomatically. probably yes, because my husband and i got sick, we were home together for weeks without separation. i had mild symptoms, post covid symptoms are fatigue, weakness, internal stress remained". the lot number for bnt162b2 was not provided and will be requested during follow up. follow-up (14feb2022): this is a spontaneous follow-up report received from a contactable consumer (patient). updated information: new events (off label use, drug use in unapproved population, covid-19, drug ineffective, post-covid syndrome, fatigue, stress, weakness) and clinical course. the lot number for bnt162b2 was not provided and will be requested during follow up.; sender's comments: linked report(s) : hu-pfizer inc-202200290569 same vaccine/reporter, different dose/event/patient (child case)
- Lab Data
-
na
- List of symptoms
-
drug ineffective fatigue asthenia product use issue off label use stress suspected covid-19 post-acute covid-19 syndrome
- Patient Died?
- No
- Date Died
- NA
- Birth defect
- false
- Vaccine Administered By:
- Other
- Vaccine Purchased By:
- Unknown
- Patient visit ER?
- No
- Patient Hospitalized?
- No
- Stay in hospital
- No
- Days in hospital
- Unspecified
- Permanent disability?
- No
- Allergies:
-
na
- Current Illness
-
breast feeding